Limb-Girdle Muscular Dystrophy 2B and Miyoshi Presentations of Dysferlinopathy
- PMID: 28502335
- DOI: 10.1016/j.amjms.2016.05.024
Limb-Girdle Muscular Dystrophy 2B and Miyoshi Presentations of Dysferlinopathy
Abstract
We report the following 2 subtypes of progressive limb-girdle dystrophy type 2B: limb-girdle muscular dystrophy type 2B (LGMD2B) and Miyoshi. The first patient described had weakness in the anterior thigh muscles (LGMD2B) and the second patient had calf muscle weakness and atrophy (Miyoshi). Literature review was performed and LGMD2B was compared and distinguished from other myopathies of similar nature. Genetic testing with polymerase chain reaction analysis of the DYSF gene confirmed the diagnosis in both patients. Additional findings of histopathology, specific stain for sarcolemmal membrane protein, Western blot analysis and clinical presentation clinched the diagnosis further of dysferlinopathy (LGMD2B) in both our patients. Currently, there is no definitive treatment on the horizon and immunosuppressive therapy is not recommended for this condition. Gene therapy may have a future role, but at present, muscle-strengthening exercises and patient awareness are the mainstays.
Keywords: Calpain; Caveolin; Dysferlin; Limb girdle muscular dystrophy 2B; Miyoshi myopathy.
Copyright © 2017 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Heterogeneous characteristics of Korean patients with dysferlinopathy.J Korean Med Sci. 2012 Apr;27(4):423-9. doi: 10.3346/jkms.2012.27.4.423. Epub 2012 Mar 21. J Korean Med Sci. 2012. PMID: 22468107 Free PMC article.
-
Case report of an adolescent girl with limb-girdle muscular dystrophy type 2B - the usefulness of muscle protein immunostaining in the diagnosis of dysferlinopathies.Folia Neuropathol. 2014;52(4):452-6. doi: 10.5114/fn.2014.47847. Folia Neuropathol. 2014. PMID: 25574751
-
Dysferlin aggregation in limb-girdle muscular dystrophy type 2B/Miyoshi Myopathy necessitates mutational screen for diagnosis [corrected].Muscle Nerve. 2013 May;47(5):740-7. doi: 10.1002/mus.23666. Epub 2013 Mar 21. Muscle Nerve. 2013. PMID: 23519732
-
Limb Girdle Muscular Dystrophy Type 2B (LGMD2B): Diagnosis and Therapeutic Possibilities.Int J Mol Sci. 2024 May 21;25(11):5572. doi: 10.3390/ijms25115572. Int J Mol Sci. 2024. PMID: 38891760 Free PMC article. Review.
-
[Mutational and clinical features of Japanese patients with dysferlinopathy (Miyoshi myopathy and limb girdle muscular dystrophy type 2B)].Rinsho Shinkeigaku. 2005 Nov;45(11):938-42. Rinsho Shinkeigaku. 2005. PMID: 16447768 Review. Japanese.
Cited by
-
Strain and sex differences in somatosensation and sociability during experimental autoimmune encephalomyelitis.Brain Behav Immun Health. 2021 Apr 28;14:100262. doi: 10.1016/j.bbih.2021.100262. eCollection 2021 Jul. Brain Behav Immun Health. 2021. PMID: 34589768 Free PMC article.
-
Phenotypic and genotypic analysis of limb-Girdle muscular dystrophy type 2B.Neurosciences (Riyadh). 2020 Jul;25(3):214-217. doi: 10.17712/nsj.2020.3.20200002. Neurosciences (Riyadh). 2020. PMID: 32683403 Free PMC article.
-
The C2 domains of dysferlin: roles in membrane localization, Ca2+ signalling and sarcolemmal repair.J Physiol. 2022 Apr;600(8):1953-1968. doi: 10.1113/JP282648. Epub 2022 Mar 8. J Physiol. 2022. PMID: 35156706 Free PMC article.
-
Novel splicing dysferlin mutation causing myopathy with intra-familial heterogeneity.Mol Biol Rep. 2020 Aug;47(8):5755-5761. doi: 10.1007/s11033-020-05643-9. Epub 2020 Jul 14. Mol Biol Rep. 2020. PMID: 32666437
-
Anesthetic management of a patient with limb-girdle muscular dystrophy 2B:CARE-compliant case report and literature review.BMC Anesthesiol. 2019 Aug 17;19(1):155. doi: 10.1186/s12871-019-0813-8. BMC Anesthesiol. 2019. PMID: 31421689 Free PMC article. Review.
Publication types
MeSH terms
Supplementary concepts
LinkOut - more resources
Full Text Sources
Other Literature Sources
